CBOE Chicago Board Options Exchange
CBOE org/CBOE Membership | CBSX Site | CFE Site | Int'l Sites | RMC Site | Careers | Contact  
Bid Now

This portion of the site is intended for research papers and market commentaries of interest to institutional options investors.

Note: Your use of 3rd Party Research is subject to the Terms and Conditions section of the CBOE Website.

Miller Tabak's Volatility Report, by Bud Haslett, CFA

Lehman Brothers. "Listed Binary Options" (July 2008).

Standard & Poor's. "Capturing the Index Effect via Options." (June 2008).

Callan Associates. "An Historical Evaluation of the CBOE S&P 500 BuyWrite Index Strategy."

Fund Evaluation Group. "Evaluation of BuyWrite and Volatility Indexes: Using the CBOE DJIA BuyWrite Index (BXD) and the CBOE DJIA Volatility Index (VXD) for Asset Allocation and Diversification Purposes."

Ibbotson Associates. "Highlights from Case Study on BXM Buy-Write Options Strategy."



Related Topics


TradeKing—$4.95/Trade: Online Options Broker, Options Trading Power E*TRADE with Options. Simulate your options trades without spending a dime. Make the move to optionsXpress and get up to $100 back. Learn More. Optionshouse: Sharp Tools, Flat Pricing Special options offer at TD AMERITRADE.
Bookmark this Page  Email This Page  Printer Friendly
 
Options involve risk and are not suitable for all investors. Prior to buying or selling an option, a person must receive a copy of Characteristics and Risks of Standardized Options (ODD). Copies of the ODD are available from your broker, by calling 1-888-OPTIONS, or from The Options Clearing Corporation, One North Wacker Drive, Suite 500, Chicago, Illinois 60606. The information on this website is provided solely for general education and information purposes and therefore should not be considered complete, precise, or current. Many of the matters discussed are subject to detailed rules, regulations, and statutory provisions which should be referred to for additional detail and are subject to changes that may not be reflected in the website information. No statement within the website should be construed as a recommendation to buy or sell a security or to provide investment advice. The inclusion of non-CBOE advertisements on the website should not be construed as an endorsement or an indication of the value of any product, service, or website. The Terms and Conditions govern use of this website and use of this website will be deemed acceptance of those Terms and Conditions.

CBOE.com Web Site/Browser Requirements